Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Not applicable Interventional Results available

Adaptive Design Study of NEST sTMS in Subjects With Major Depressive Disorder

ClinicalTrials.gov ID: NCT03288714

Public ClinicalTrials.gov record NCT03288714. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Jul 21, 2026, 4:42 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Prospective, Multicenter, Double-Blind, Sham-Controlled Adaptive Design Study to Confirm the Safety and Efficacy of NEST sTMS in Subjects With Major Depressive Disorder Who Have Not Responded to at Least One Antidepressant Medication in the Current Episode

Study identification

NCT ID
NCT03288714
Recruitment status
Completed
Study type
Interventional
Phase
Not applicable
Lead sponsor
Wave Neuroscience
Industry
Enrollment
121 participants

Conditions and interventions

Interventions

  • Synchronized Transcranial Magnetic Stimulation (sTMS) Device
  • Sham Stimulation Device

Device

Eligibility (public fields only)

Age range
22 Years to 65 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Nov 26, 2017
Primary completion
Feb 28, 2019
Completion
May 31, 2019
Last update posted
Sep 4, 2021

2017 – 2019

United States locations

U.S. sites
14
U.S. states
11
U.S. cities
14
Facility City State ZIP Site status
Kadima Neuropsychiatry Institute La Jolla California 92037
UCLA Westwood - Semel Institute for Neuroscience and Human Behavior Los Angeles California 90024
Stanford University Stanford California 94305
Emory University Atlanta Georgia 30329
Sheppard Pratt Health System Baltimore Maryland 21204
Beth Israel Deaconess Medical Center Boston Massachusetts 02215
Mayo Clinic Rochester Minnesota 55905
Washington University/Barnes Jewish Hospital St Louis Missouri 63110
New York University New York New York 10016
Laureate Institute for Brain Research Tulsa Oklahoma 74136
University of Pennsylvania Philadelphia Pennsylvania 19104
Butler Hospital Providence Rhode Island 02906
University of Texas Southwestern Medical Center Dallas Texas 75390
Brain Health Consultants Houston Texas 77046

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT03288714, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Sep 4, 2021 · Synced Jul 21, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT03288714 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →